Speaker Profile
M.D., Ph.D., MBA, Vitreoretinal Surgeon-Scientist, ClinOmicsAI
Biography
Dr. David R.P. Almeida is a distinguished vitreoretinal surgeon and clinical scientist recognized for his extensive contributions to ophthalmic research and innovative patient care. He serves as the Founder and Executive Chairman of Almeida Pharma and The Centers for Advanced Surgical Exploration (CASEx), where he leads pioneering international clinical research initiatives. His primary research interests include precision arbitrage in age-related macular degeneration, diabetic eye disease, and advancing techniques in complex vitreoretinal surgery.
A prolific and respected thought leader, Dr. Almeida has authored over 270 peer-reviewed publications and delivered more than 200 presentations at major medical conferences worldwide. He has served as the Principal Investigator for over 140 clinical trials across all phases of development.
Talk
The Eye as a Liquid Biopsy Window
A 100-microliter aqueous humor tap yields a proteome that reads systemic and ocular disease in real time. Across 60+ trials at Erie Retina Research, ClinOmicsAI pairs that signal with imaging and AI to monitor gene therapy expression, GLP-1 effects and treatment response, moving precision ophthalmology from discovery to clinic.
AI for Emerging Therapeutics Showcase:
ClinOmicsAI
Precision Proteomics
Session Abstract – PMWC 2027 Silicon Valley
The PMWC 2027 AI for Emerging Therapeutics Showcase will provide a 15-30 minute time slot for selected companies to explore the transformative role of artificial intelligence in accelerating the discovery, development, and optimization of novel therapeutic modalities. From predictive algorithms for drug efficacy to real-time analysis in clinical trials, AI is revolutionizing the way we approach emerging therapies, including RNA-based treatments, gene editing, and personalized medicine. Industry leaders and experts will discuss AI-driven advancements, collaborative frameworks, and the challenges of integrating cutting-edge technologies into therapeutic innovation. Join us for an in-depth look at how AI is shaping the future of breakthrough therapeutics.
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
